ARTA
ADAP
A.R.T. Advisors’s Adaptimmune Therapeutics ADAP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-10,335
| Closed | -$56K | – | 53 |
|
|
2020
Q4 | $56K | Buy |
+10,335
| New | +$56K | 0.26% | 67 |
|
|
2019
Q2 | – | Sell |
-24,111
| Closed | -$104K | – | 1317 |
|
|
2019
Q1 | $104K | Buy |
+24,111
| New | +$104K | 0.01% | 1167 |
|
|
2018
Q2 | – | Sell |
-84,925
| Closed | -$953K | – | 1377 |
|
|
2018
Q1 | $953K | Buy |
+84,925
| New | +$953K | 0.04% | 683 |
|
|
2017
Q4 | – | Sell |
-39,158
| Closed | -$320K | – | 1327 |
|
|
2017
Q3 | $320K | Buy |
39,158
+15,050
| +62% | +$123K | 0.02% | 984 |
|
|
2017
Q2 | $108K | Sell |
24,108
-9,665
| -29% | -$43.3K | 0.01% | 1247 |
|
|
2017
Q1 | $186K | Buy |
+33,773
| New | +$186K | 0.01% | 1175 |
|
|
2016
Q2 | – | Sell |
-21,600
| Closed | -$175K | – | 1318 |
|
|
2016
Q1 | $175K | Sell |
21,600
-400
| -2% | -$3.24K | 0.01% | 1196 |
|
|
2015
Q4 | $265K | Buy |
+22,000
| New | +$265K | 0.01% | 1100 |
|